We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENDP
426
DELISTED
Endo International plc
ENDP
$7.02M 0.04%
+744,268
New +$5M
PRMW
427
DELISTED
Primo Water Corporation
PRMW
$7.01M 0.04%
423,410
+277,127
+189% +$4.3M
PPC icon
428
Pilgrim's Pride
PPC
$6.54B
$7M 0.04%
347,775
+85,415
+33% +$1.84M
KTOS icon
429
Kratos Defense & Security Solutions
KTOS
$11.4B
$6.94M 0.04%
602,630
+31,504
+6% +$347K
AMGN icon
430
Amgen
AMGN
$222B
$6.91M 0.04%
+37,458
New +$6.63M
AMP icon
431
Ameriprise Financial
AMP
$48.8B
$6.89M 0.04%
49,270
+46,811
+1,904% +$6.63M
HLT icon
432
Hilton Worldwide
HLT
$71.5B
$6.89M 0.04%
87,038
+83,818
+2,603% +$6.82M
IOVA icon
433
Iovance Biotherapeutics
IOVA
$2.87B
$6.88M 0.04%
537,668
-1,141,303
-68% -$16.7M
PAG icon
434
Penske Automotive Group
PAG
$14.2B
$6.85M 0.04%
+146,147
New +$6.89M
GPOR
435
DELISTED
Gulfport Energy Corp.
GPOR
$6.82M 0.04%
542,884
+421,033
+346% +$4.34M
RRC icon
436
Range Resources
RRC
$8.95B
$6.82M 0.04%
407,625
+322,273
+378% +$4.88M
AAN.A
437
DELISTED
The Aaron's Company Inc Class A
AAN.A
$6.8M 0.04%
+156,538
New +$6.8M
EGRX
438
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$6.79M 0.04%
89,760
+38,338
+75% +$2.41M
SFIX
439
Stitch Fix
SFIX
$560M
$6.79M 0.04%
247,291
+116,848
+90% +$2.65M
ODP
440
DELISTED
ODP
ODP
$6.77M 0.04%
+265,361
New +$6.45M
PODD icon
441
Insulet
PODD
$9.79B
$6.74M 0.04%
78,631
+63,396
+416% +$5.69M
FE icon
442
FirstEnergy
FE
$27.5B
$6.71M 0.04%
186,755
-39,088
-17% -$1.34M
MIME
443
DELISTED
Mimecast Limited
MIME
$6.7M 0.04%
162,564
-57,273
-26% -$2.33M
PRGS icon
444
Progress Software
PRGS
$1.76B
$6.67M 0.04%
171,803
-79,639
-32% -$3.02M
IRTC icon
445
iRhythm Holdings
IRTC
$4.2B
$6.66M 0.04%
+82,081
New +$5.74M
DEI icon
446
Douglas Emmett
DEI
$1.96B
$6.63M 0.04%
+164,902
New +$6.23M
AERI
447
DELISTED
Aerie Pharmaceuticals
AERI
$6.59M 0.04%
+97,628
New +$5.46M
VET icon
448
Vermilion Energy
VET
$1.66B
$6.59M 0.04%
+182,766
New +$6.32M
MFIC icon
449
MidCap Financial Investment
MFIC
$804M
$6.57M 0.04%
393,105
-206,846
-34% -$3.44M
JBHT icon
450
JB Hunt Transport Services
JBHT
$25.2B
$6.54M 0.04%
+53,764
New +$6.58M
16 17
18
19 20

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.